Trading Specifications
Minimum Price Fluctuation
--
Spreads as low as
--
Average Spreads
--
Minimum Lot Size
--
Commission
--
Trading Hours(GMT+2)
--
Maximum Trading Volume (lots)
--
News
Jefferies cuts CureVac stock rating to hold on BioNTech acquisition
CureVac’s SWOT analysis: mRNA pioneer’s stock faces pivotal year ahead
Oracle and CureVac rise premarket; Boeing and GameStop fall
CureVac stock soars about 30% after BioNTech agrees to acquire co
BioNTech to acquire CureVac in $1.25 billion all-stock deal
CureVac stock maintains $10 target from JMP on GBM vaccine outlook
CureVac Announces Financial Results for the First Quarter of 2025 and Provides Business Updates
CureVac Receives Additional Positive Validity Decision from European Patent Office in Ongoing Litigation Against BioNTech SE
CureVac NV earnings beat by €0.06, revenue topped estimates
CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2024 and Provides Business Update
